esle {
}
Authoring of TR 56-3 Phase Appropriate Application of GMPs for Vaccines
- Application Deadline
- 24 May, 2024
- Openings
- 15
- Type
- Virtual Writing
- Location
- Virtual, in-person
This annex to TR 56 will address specific aspects of vaccine manufacturing and help provide insight as to how to apply GMPs to the accelerated development process involved with vaccines, including application of prior knowledge and platform technologies.
This is a virtual and in-person opportunity.
Available to Members only.
Skills
- Biotech
- Quality and Compliance